COPD inhaled drug therapy in primary health care: an integrated view

Bibliographic Details
Main Author: Costa, Rodrigo
Publication Date: 2023
Other Authors: P. Costa, Rui
Format: Article
Language: por
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://doi.org/10.32385/rpmgf.v39i3.13607
Summary: COPD is a chronic disabling disease with persistent respiratory symptoms and airflow limitation. It is frequently related to comorbidities that must be managed in an integrated way. Inhalation therapy is the therapy of choice for the treatment of COPD patients. When monotherapy is chosen, long-acting anticholinergics should be preferred. Dual bronchodilation is the most appropriate baseline treatment for most patients with COPD. Triple therapy is required for a subpopulation of these patients, and general practitioners/family doctors must be qualified to prescribe it. Teaching and regular assessment of inhalation techniques are key to therapeutic success. The adoption of the acronym EDUCAR (Explain, Demonstrate, Use, Correct, Annotate, Reassess) is proposed to be applied in all appointments of people using inhaled therapy to achieve the greatest benefit for the patient.
id RCAP_59367ab1346a1b6e8e0783f4ef3b1f15
oai_identifier_str oai:ojs.rpmgf.pt:article/13607
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling COPD inhaled drug therapy in primary health care: an integrated viewTerapêutica farmacológica inalada da DPOC nos cuidados de saúde primários: uma visão integradaCOPDInhalersBronchodilatorsExacerbationLung functionDPOCInaladoresBroncodilatadoresAgudizaçãoFunção pulmonarCOPD is a chronic disabling disease with persistent respiratory symptoms and airflow limitation. It is frequently related to comorbidities that must be managed in an integrated way. Inhalation therapy is the therapy of choice for the treatment of COPD patients. When monotherapy is chosen, long-acting anticholinergics should be preferred. Dual bronchodilation is the most appropriate baseline treatment for most patients with COPD. Triple therapy is required for a subpopulation of these patients, and general practitioners/family doctors must be qualified to prescribe it. Teaching and regular assessment of inhalation techniques are key to therapeutic success. The adoption of the acronym EDUCAR (Explain, Demonstrate, Use, Correct, Annotate, Reassess) is proposed to be applied in all appointments of people using inhaled therapy to achieve the greatest benefit for the patient.A DPOC é uma doença crónica incapacitante e caracterizada por sintomas respiratórios persistentes e por limitação do fluxo aéreo. Está frequentemente associada a múltiplas comorbilidades que devem ser geridas de forma integrada. A terapêutica inalatória é a terapêutica de eleição no tratamento dos doentes com DPOC. Quando se opta pela monoterapia, os anticolinérgicos de longa duração de ação devem ser privilegiados. A dupla broncodilatação é o tratamento basilar mais adequado para a maioria das pessoas com DPOC. A terapêutica tripla é necessária para uma subpopulação destes doentes, devendo o médico de família estar capacitado para a sua prescrição. O ensino e a avaliação regular da técnica inalatória são fundamentais para o sucesso terapêutico. Sugere-se a adoção do acrónimo EDUCAR (Explicar, Demonstrar, Usar, Corrigir, Anotar, Reavaliar) a ser aplicado em todas as oportunidades de consulta das pessoas sob terapêutica inalada, de forma a conseguir o maior benefício para o doente.Associação Portuguesa de Medicina Geral e Familiar2023-07-05info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.32385/rpmgf.v39i3.13607https://doi.org/10.32385/rpmgf.v39i3.13607Portuguese Journal of Family Medicine and General Practice; Vol. 39 No. 3 (2023): Revista Portuguesa de Medicina Geral e Familiar; 248-55Revista Portuguesa de Medicina Geral e Familiar; Vol. 39 Núm. 3 (2023): Revista Portuguesa de Medicina Geral e Familiar; 248-55Revista Portuguesa de Medicina Geral e Familiar; Vol. 39 N.º 3 (2023): Revista Portuguesa de Medicina Geral e Familiar; 248-552182-51812182-517310.32385/rpmgf.v39i3reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAPporhttps://rpmgf.pt/ojs/index.php/rpmgf/article/view/13607https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13607/11870Direitos de Autor (c) 2023 Revista Portuguesa de Medicina Geral e Familiarinfo:eu-repo/semantics/openAccessCosta, RodrigoP. Costa, Rui2024-09-17T12:00:41Zoai:ojs.rpmgf.pt:article/13607Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T18:52:53.415796Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv COPD inhaled drug therapy in primary health care: an integrated view
Terapêutica farmacológica inalada da DPOC nos cuidados de saúde primários: uma visão integrada
title COPD inhaled drug therapy in primary health care: an integrated view
spellingShingle COPD inhaled drug therapy in primary health care: an integrated view
Costa, Rodrigo
COPD
Inhalers
Bronchodilators
Exacerbation
Lung function
DPOC
Inaladores
Broncodilatadores
Agudização
Função pulmonar
title_short COPD inhaled drug therapy in primary health care: an integrated view
title_full COPD inhaled drug therapy in primary health care: an integrated view
title_fullStr COPD inhaled drug therapy in primary health care: an integrated view
title_full_unstemmed COPD inhaled drug therapy in primary health care: an integrated view
title_sort COPD inhaled drug therapy in primary health care: an integrated view
author Costa, Rodrigo
author_facet Costa, Rodrigo
P. Costa, Rui
author_role author
author2 P. Costa, Rui
author2_role author
dc.contributor.author.fl_str_mv Costa, Rodrigo
P. Costa, Rui
dc.subject.por.fl_str_mv COPD
Inhalers
Bronchodilators
Exacerbation
Lung function
DPOC
Inaladores
Broncodilatadores
Agudização
Função pulmonar
topic COPD
Inhalers
Bronchodilators
Exacerbation
Lung function
DPOC
Inaladores
Broncodilatadores
Agudização
Função pulmonar
description COPD is a chronic disabling disease with persistent respiratory symptoms and airflow limitation. It is frequently related to comorbidities that must be managed in an integrated way. Inhalation therapy is the therapy of choice for the treatment of COPD patients. When monotherapy is chosen, long-acting anticholinergics should be preferred. Dual bronchodilation is the most appropriate baseline treatment for most patients with COPD. Triple therapy is required for a subpopulation of these patients, and general practitioners/family doctors must be qualified to prescribe it. Teaching and regular assessment of inhalation techniques are key to therapeutic success. The adoption of the acronym EDUCAR (Explain, Demonstrate, Use, Correct, Annotate, Reassess) is proposed to be applied in all appointments of people using inhaled therapy to achieve the greatest benefit for the patient.
publishDate 2023
dc.date.none.fl_str_mv 2023-07-05
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.32385/rpmgf.v39i3.13607
https://doi.org/10.32385/rpmgf.v39i3.13607
url https://doi.org/10.32385/rpmgf.v39i3.13607
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13607
https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13607/11870
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2023 Revista Portuguesa de Medicina Geral e Familiar
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2023 Revista Portuguesa de Medicina Geral e Familiar
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Associação Portuguesa de Medicina Geral e Familiar
publisher.none.fl_str_mv Associação Portuguesa de Medicina Geral e Familiar
dc.source.none.fl_str_mv Portuguese Journal of Family Medicine and General Practice; Vol. 39 No. 3 (2023): Revista Portuguesa de Medicina Geral e Familiar; 248-55
Revista Portuguesa de Medicina Geral e Familiar; Vol. 39 Núm. 3 (2023): Revista Portuguesa de Medicina Geral e Familiar; 248-55
Revista Portuguesa de Medicina Geral e Familiar; Vol. 39 N.º 3 (2023): Revista Portuguesa de Medicina Geral e Familiar; 248-55
2182-5181
2182-5173
10.32385/rpmgf.v39i3
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833597727653494784

Similar Items